\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ laboratory\\:\\ left\\ breast\\ tenderness\\ on\\ palpation\\.\\ \\ no\\ masses\\,\\ nodules\\ or\\ changes\\ in\\ the\\ skin\\.\ \(0\)\
\-\ treatment\\ and\\ follow\\-up\\:\\ pt\\ had\\ mri\\ guided\\ placement\\ of\\ a\\ wire\\.\\ \\ breast\\ was\\ reimaged\\ with\\ mammogram\\ after\\ the\\ wire\\ placement\\ to\\ help\\ the\\ surgeon\\ better\\ locate\\ the\\ mass\\.\\ \\ a\\ 6\\ mm\\ focus\\ of\\ dcis\\ was\\ excised\\.\ \(0\)\
\-\ image\\ findings\\:\\ breast\\ mri\\ showed\\ spiculated\\ enhancing\\ mass\\ in\\ anterior\\ 1\\/3\\ of\\ left\\ breast\\.\ \(0\)\
\-\ ductal\\ carcinoma\\ in\\ situ\\ \\(dcis\\)\ \(0\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\\ \ \(0\)\
\-\ malignant\\ neoplasm\\â\\€\\”ductal\\ carcinoma\\,\\ lobular\\ carcinoma\\,\\ inflammatory\\ carcinoma\ \(0\)\
\-\ fibroadenoma\ \(22\)\
\-\ abscess\ \(594\)\
\-\ history\\ \\(can\\ include\\ gestational\\ age\\,\\ or\\ age\\ in\\ days\\,\\ weeks\\,\\ months\\)\\:\\ 59\\ y\\/o\\ female\\ with\\ focal\\ left\\ breast\\ pain\\ x\\ 2\\-3\\ months\\ with\\ increased\\ risk\\ by\\ the\\ gail\\ model\\.\\ \\ mammogram\\ was\\ normal\\.\\ \\ breast\\ ultrasound\\ was\\ normal\\ without\\ any\\ evidence\\ of\\ mass\\ or\\ cystic\\ structure\\.\ \(0\)\
\-\ discussion\\ \\(include\\ references\\)\\:\\ given\\ the\\ increased\\ use\\ of\\ mammographic\\ screening\\ over\\ the\\ past\\ few\\ decades\\,\\ the\\ dcis\\ is\\ the\\ most\\ rapidly\\ growing\\ subgroup\\ of\\ breast\\ cancer\\.\\ \\ dcis\\ was\\ newly\\ diagnosed\\ over\\ 55\\,000\\ times\\ in\\ 2003\\.\\ \\ as\\ a\\ direct\\ precursor\\ to\\ invasive\\ breast\\ cancer\\,\\ diagnosing\\ dcis\\ is\\ important\\ to\\ preventing\\ widespread\\ disease\\.\\ \\ \\ for\\ a\\ pt\\ such\\ as\\ this\\,\\ where\\ mammography\\ and\\ us\\ showed\\ no\\ abnormalities\\,\\ but\\ she\\ was\\ still\\ having\\ pain\\,\\ mri\\ is\\ a\\ logical\\ next\\ step\\.\\ \\ almost\\ all\\ invasive\\ cancers\\ will\\ enhance\\ with\\ gadolinium\\ on\\ mri\\ \\(95\\-100\\%\\ sensitivity\\)\\;\\ it\\ is\\ less\\ for\\ dcis\\.\\ \\ however\\,\\ in\\ this\\ pt\\ it\\ did\\ enhance\\.\\ \\ also\\ of\\ note\\,\\ mri\\ can\\ be\\ helpful\\ in\\ determining\\ the\\ extent\\ of\\ disease\\ spread\\ posteriorly\\ \\(chest\\ wall\\,\\ muscle\\,\\ etc\\.\\)\\ \\ however\\,\\ the\\ routine\\ use\\ of\\ breast\\ mri\\ is\\ being\\ studied\\ and\\ compared\\ with\\ that\\ of\\ mammagraphy\\.\\ \\ mri\\ is\\ often\\ much\\ more\\ expensive\\,\\ less\\ available\\,\\ and\\ may\\ have\\ a\\ higher\\ false\\ positive\\ rate\\ for\\ enhancing\\ benign\\ lesions\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dcis\\:\\ 0\\.10746278398001681\ \(0\)\
\-\ breast\\:\\ 0\\.0832053416260263\ \(0\)\
\-\ mri\\:\\ 0\\.040301850394141754\ \(0\)\
\-\ wire\\:\\ 0\\.035820927993338934\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02840970873918905\ \(0\)\
\-\ pt\\:\\ 0\\.027951587284159116\ \(0\)\
\-\ mammogram\\:\\ 0\\.026151375937107958\ \(0\)\
\-\ neoplasm\\â\\€\\”ductal\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ gail\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ subgroup\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ 55\\,000\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ logical\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ mammagraphy\\:\\ 0\\.025851960187585038\ \(0\)\
\-\ invasive\\:\\ 0\\.025183166257580398\ \(0\)\
\-\ enhance\\:\\ 0\\.02424274015743272\ \(0\)\
\-\ 95\\-100\\:\\ 0\\.023819270508523616\ \(0\)\
\-\ reimaged\\:\\ 0\\.02263022327066976\ \(0\)\
\-\ expensive\\:\\ 0\\.021786580829462193\ \(0\)\
\-\ placement\\:\\ 0\\.02034258588415853\ \(0\)\
\-\ locate\\:\\ 0\\.02014547881205626\ \(0\)\
\-\ precursor\\:\\ 0\\.02014547881205626\ \(0\)\
\-\ studied\\:\\ 0\\.02014547881205626\ \(0\)\
\-\ \\:\\:\\ 0\\.019887533419190587\ \(0\)\
\-\ use\\:\\ 0\\.019809027067702656\ \(0\)\
\-\ model\\:\\ 0\\.019753891150400767\ \(0\)\
\-\ step\\:\\ 0\\.018820009240962252\ \(0\)\
\-\ mammographic\\:\\ 0\\.018112789132994838\ \(0\)\
\-\ 2003\\.\\:\\ 0\\.018112789132994838\ \(0\)\
\-\ was\\:\\ 0\\.017389047311677775\ \(0\)\
\-\ preventing\\:\\ 0\\.017066821555461898\ \(0\)\
\-\ less\\:\\ 0\\.016973255157317787\ \(0\)\
\-\ widespread\\:\\ 0\\.016787319561900826\ \(0\)\
\-\ newly\\:\\ 0\\.016656962486913045\ \(0\)\
\-\ determining\\:\\ 0\\.01653215423348549\ \(0\)\
\-\ cancer\\:\\ 0\\.016476042606244957\ \(0\)\
\-\ showed\\:\\ 0\\.016432863741487957\ \(0\)\
\-\ 1\\/3\\:\\ 0\\.016297424885469255\ \(0\)\
\-\ situ\\:\\ 0\\.016297424885469255\ \(0\)\
\-\ decades\\:\\ 0\\.016080099453933412\ \(0\)\
\-\ diagnosing\\:\\ 0\\.01597719235771268\ \(0\)\
\-\ fibroadenoma\\:\\ 0\\.01587777431760804\ \(0\)\
\-\ false\\:\\ 0\\.01587777431760804\ \(0\)\
\-\ excised\\:\\ 0\\.015781616479417455\ \(0\)\
\-\ enhancing\\:\\ 0\\.015718202538913543\ \(0\)\
\-\ guided\\:\\ 0\\.015262758097719277\ \(0\)\
\-\ spiculated\\:\\ 0\\.015262758097719277\ \(0\)\
\-\ age\\:\\ 0\\.015254606014922619\ \(0\)\
\-\ cancers\\:\\ 0\\.015108377647615402\ \(0\)\
\-\ mammography\\:\\ 0\\.014561204757350264\ \(0\)\
\-\ \\,\\:\\ 0\\.014289680877745375\ \(0\)\
\-\ lobular\\:\\ 0\\.014154059757777782\ \(0\)\
\-\ sensitivity\\:\\ 0\\.014154059757777782\ \(0\)\
\-\ include\\:\\ 0\\.014059551249444496\ \(0\)\
\-\ however\\:\\ 0\\.013955237862739415\ \(0\)\
\-\ rapidly\\:\\ 0\\.013894372375544806\ \(0\)\
\-\ growing\\:\\ 0\\.01384508463854662\ \(0\)\
\-\ months\\:\\ 0\\.013688805247449075\ \(0\)\
\-\ etc\\:\\ 0\\.013565582644985549\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.013521483297875463\ \(0\)\
\-\ 59\\:\\ 0\\.013478037298505547\ \(0\)\
\-\ surgeon\\:\\ 0\\.013351432688930156\ \(0\)\
\-\ gestational\\:\\ 0\\.013351432688930156\ \(0\)\
\-\ helpful\\:\\ 0\\.012965012519923927\ \(0\)\
\-\ better\\:\\ 0\\.012929029843701598\ \(0\)\
\-\ over\\:\\ 0\\.012760367097595088\ \(0\)\
\-\ next\\:\\ 0\\.012721940203777982\ \(0\)\
\-\ help\\:\\ 0\\.012497482499606914\ \(0\)\
\-\ extent\\:\\ 0\\.012436385470566321\ \(0\)\
\-\ higher\\:\\ 0\\.012288990060651692\ \(0\)\
\-\ increased\\:\\ 0\\.012260907811141676\ \(0\)\
\-\ times\\:\\ 0\\.01214864982259411\ \(0\)\
\-\ almost\\:\\ 0\\.01212137007871636\ \(0\)\
\-\ spread\\:\\ 0\\.01212137007871636\ \(0\)\
\-\ still\\:\\ 0\\.01193720321291275\ \(0\)\
\-\ gadolinium\\:\\ 0\\.011886640730700122\ \(0\)\
\-\ direct\\:\\ 0\\.011836935281099616\ \(0\)\
\-\ posteriorly\\:\\ 0\\.011836935281099616\ \(0\)\
\-\ ductal\\:\\ 0\\.011812394959485198\ \(0\)\
\-\ discussion\\:\\ 0\\.011739982605847743\ \(0\)\
\-\ much\\:\\ 0\\.011600310907932041\ \(0\)\
\-\ having\\:\\ 0\\.01151076039807843\ \(0\)\
\-\ structure\\:\\ 0\\.011381362143213508\ \(0\)\
\-\ can\\:\\ 0\\.011367873035009206\ \(0\)\
\-\ few\\:\\ 0\\.01127772763750879\ \(0\)\
\-\ it\\:\\ 0\\.011265972929812414\ \(0\)\
\-\ focus\\:\\ 0\\.011257433083712387\ \(0\)\
\-\ important\\:\\ 0\\.011257433083712387\ \(0\)\
\-\ screening\\:\\ 0\\.01068925052471656\ \(0\)\
\-\ findings\\:\\ 0\\.010667665312551084\ \(0\)\
\-\ compared\\:\\ 0\\.010607100858359744\ \(0\)\
\-\ \\(\\:\\ 0\\.010591814167798542\ \(0\)\
\-\ us\\:\\ 0\\.010511465710005606\ \(0\)\
\-\ \\)\\:\\ 0\\.01046242950312764\ \(0\)\
\-\ mass\\:\\ 0\\.01045566868282315\ \(0\)\
\-\ references\\:\\ 0\\.01041885112921294\ \(0\)\
\-\ nodules\\:\\ 0\\.010388618373615106\ \(0\)\
\-\ where\\:\\ 0\\.010227689897879522\ \(0\)\
\-\ routine\\:\\ 0\\.010048230774633423\ \(0\)\
\-\ is\\:\\ 0\\.009893679385068486\ \(0\)\
\-\ in\\:\\ 0\\.009886152026750849\ \(0\)\
\-\ rate\\:\\ 0\\.0097675117022752\ \(0\)\
\-\ note\\:\\ 0\\.009671746414961262\ \(0\)\
\-\ skin\\:\\ 0\\.009625011540290258\ \(0\)\
\-\ laboratory\\:\\ 0\\.009234873125671748\ \(0\)\
\-\ mm\\:\\ 0\\.009214648553651042\ \(0\)\
\-\ diagnosed\\:\\ 0\\.009214648553651042\ \(0\)\
\-\ abnormalities\\:\\ 0\\.009204588333425854\ \(0\)\
\-\ risk\\:\\ 0\\.009076852338296441\ \(0\)\
\-\ malignant\\:\\ 0\\.00905768526797449\ \(0\)\
\-\ did\\:\\ 0\\.009048148507310626\ \(0\)\
\-\ muscle\\:\\ 0\\.009000924438200424\ \(0\)\
\-\ or\\:\\ 0\\.008811050577393321\ \(0\)\
\-\ being\\:\\ 0\\.008732516060998705\ \(0\)\
\-\ inflammatory\\:\\ 0\\.008690076082674556\ \(0\)\
\-\ benign\\:\\ 0\\.00864824154555191\ \(0\)\
\-\ given\\:\\ 0\\.008590658042569919\ \(0\)\
\-\ for\\:\\ 0\\.008552588253873492\ \(0\)\
\-\ masses\\:\\ 0\\.008470945448668877\ \(0\)\
\-\ this\\:\\ 0\\.008455752609801758\ \(0\)\
\-\ available\\:\\ 0\\.008424396037653364\ \(0\)\
\-\ left\\:\\ 0\\.008411483307386348\ \(0\)\
\-\ palpation\\:\\ 0\\.00836345771363065\ \(0\)\
\-\ x\\:\\ 0\\.00826705670189876\ \(0\)\
\-\ disease\\:\\ 0\\.008192009039388295\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.008152601147922997\ \(0\)\
\-\ positive\\:\\ 0\\.008131629297020871\ \(0\)\
\-\ often\\:\\ 0\\.007995523602696928\ \(0\)\
\-\ past\\:\\ 0\\.007962461794564323\ \(0\)\
\-\ differential\\:\\ 0\\.0079558939277212\ \(0\)\
\-\ abscess\\:\\ 0\\.007923273443208995\ \(0\)\
\-\ any\\:\\ 0\\.007891011827191477\ \(0\)\
\-\ normal\\:\\ 0\\.007856964543103232\ \(0\)\
\-\ will\\:\\ 0\\.007840120288501883\ \(0\)\
\-\ such\\:\\ 0\\.007833820498067015\ \(0\)\
\-\ image\\:\\ 0\\.007827534212016424\ \(0\)\
\-\ days\\:\\ 0\\.007680569783495535\ \(0\)\
\-\ tenderness\\:\\ 0\\.007621443762116226\ \(0\)\
\-\ as\\:\\ 0\\.007581099741314532\ \(0\)\
\-\ 6\\:\\ 0\\.007484223347140394\ \(0\)\
\-\ ultrasound\\:\\ 0\\.007434377082129922\ \(0\)\
\-\ wall\\:\\ 0\\.00725853114439515\ \(0\)\
\-\ cystic\\:\\ 0\\.007227661898098999\ \(0\)\
\-\ changes\\:\\ 0\\.007181958874589621\ \(0\)\
\-\ focal\\:\\ 0\\.007156872739408803\ \(0\)\
\-\ weeks\\:\\ 0\\.0071122514865136315\ \(0\)\
\-\ all\\:\\ 0\\.007087752168420208\ \(0\)\
\-\ she\\:\\ 0\\.007034563464674992\ \(0\)\
\-\ a\\:\\ 0\\.006978295633171871\ \(0\)\
\-\ y\\/o\\:\\ 0\\.006940261084515075\ \(0\)\
\-\ lesions\\:\\ 0\\.006708388581653806\ \(0\)\
\-\ evidence\\:\\ 0\\.006570212854448322\ \(0\)\
\-\ these\\:\\ 0\\.0065215386860933726\ \(0\)\
\-\ anterior\\:\\ 0\\.00645393789959747\ \(0\)\
\-\ more\\:\\ 0\\.006267379206194036\ \(0\)\
\-\ physical\\:\\ 0\\.006148109294959643\ \(0\)\
\-\ pain\\:\\ 0\\.00612086901777557\ \(0\)\
\-\ chest\\:\\ 0\\.0059962727274414035\ \(0\)\
\-\ \\;\\:\\ 0\\.0059396515790398645\ \(0\)\
\-\ without\\:\\ 0\\.005900331866152963\ \(0\)\
\-\ \\%\\:\\ 0\\.005845516226821137\ \(0\)\
\-\ most\\:\\ 0\\.005785440298322803\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00575430888791912\ \(0\)\
\-\ exam\\:\\ 0\\.005505084867887209\ \(0\)\
\-\ may\\:\\ 0\\.005496564131666052\ \(0\)\
\-\ case\\:\\ 0\\.005482417691692876\ \(0\)\
\-\ have\\:\\ 0\\.005426504628636633\ \(0\)\
\-\ had\\:\\ 0\\.005407184220647238\ \(0\)\
\-\ but\\:\\ 0\\.005344584460508908\ \(0\)\
\-\ after\\:\\ 0\\.005184754259851034\ \(0\)\
\-\ female\\:\\ 0\\.005151789652339688\ \(0\)\
\-\ treatment\\:\\ 0\\.005072190497363305\ \(0\)\
\-\ no\\:\\ 0\\.005046593259259836\ \(0\)\
\-\ also\\:\\ 0\\.004940233412522438\ \(0\)\
\-\ the\\:\\ 0\\.004459654345278252\ \(0\)\
\-\ that\\:\\ 0\\.004328389233310332\ \(0\)\
\-\ on\\:\\ 0\\.004245695087187262\ \(0\)\
\-\ by\\:\\ 0\\.004172641944999633\ \(0\)\
\-\ be\\:\\ 0\\.0038643892180173873\ \(0\)\
\-\ to\\:\\ 0\\.003757197434982284\ \(0\)\
\-\ history\\:\\ 0\\.0034610397000207726\ \(0\)\
\-\ of\\:\\ 0\\.0034165337477415963\ \(0\)\
\-\ and\\:\\ 0\\.002639428236542793\ \(0\)\
\-\ \\.\\:\\ 0\\.0017697715942958552\ \(0\)\
\-\ with\\:\\ 0\\.0017156037549837205\ \(0\)\
